Dante Labs acquires Cambridge Cancer Genomics to create global excellence in precision oncology
Integrated single software platform will enable true patient-centric precision oncology at scale for cancer patients care combining medical, germline, somatic and liquid biopsy data analysis together. Cambridge Cancer Genomics OncOS machine learning oncology software will be integrated in Dante Labs CE-IVD, ISO13485 Immensa Genomics Interpretation Software, and it will become available to clinical and research […]